Ladenburg Thalmann Financial Services’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-55	Closed	-$2K	–	5101
2016 Q3	$2K	Hold	55	–	–	﹤0.01%	4568
2016 Q2	$1K	Hold	55	–	–	﹤0.01%	4701
2016 Q1	$0	Hold	55	–	–	﹤0.01%	4958
2015 Q4	$1K	Hold	55	–	–	﹤0.01%	4622
2015 Q3	$1K	Hold	55	–	–	﹤0.01%	4539
2015 Q2	$1K	Sell	55 -1	-2%	-$15	﹤0.01%	4600
2015 Q1	$1K	Hold	56	–	–	﹤0.01%	4520
2014 Q4	$0	Hold	56	–	–	﹤0.01%	4525
2014 Q3	$1K	Hold	56	–	–	﹤0.01%	3868
2014 Q2	$3K	Buy	+56	New	+$3.41K	﹤0.01%	3582

Ladenburg Thalmann Financial Services's TBRA Position: Q4 2016 in Review

Ladenburg Thalmann Financial Services sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 55 shares — an estimated $2K sold.

Ladenburg Thalmann Financial Services first reported a position in TBRA in Q2 2014 and held it in 10 quarters. The position peaked at $3K in Q2 2014. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Ladenburg Thalmann Financial Services reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 55 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2K.
Ladenburg Thalmann Financial Services first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
Ladenburg Thalmann Financial Services's Tobira Therapeutics, Inc. Common Stock position peaked at $3K in Q2 2014.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2016, filed 14 Feb 2017.